Home/ Stocks/ BNTC

Benitec Biopharma Inc. Common Stock

BNTC XNAS

$11.36 +0.32 (+2.90%) ▲ 15-min delayed

Open

$11.27

High

$11.55

Low

$11.15

Volume

91.3K

Market Cap

$385.11M

About Benitec Biopharma Inc. Common Stock

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on advancing novel genetic medicines. Its technology could provide a one-shot cure for a wide range of diseases that require strict, ongoing treatment regimens or have no effective treatment or only palliative care options. The Company is developing a silence-and-replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The company has a single operating segment, which is the business of discovery and development of therapeutic agents for the treatment of genetic disorders.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 24 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2026	$0	$-45,546,000	$-0.98
FY 2026	$0	$-45,546,000	$-0.98
Q3 2026	$0	$-11,935,000	$-0.24
Q2 2026	$0	$-11,837,000	$-0.26

Earnings & Analyst Ratings

Next Earnings: Thu, Nov 12, 2026

Calendar →

Related Market News

No specific coverage for BNTC yet. Check out our latest market news or earnings calendar.

Get BNTC Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Benitec Biopharma Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.